← Back to Search

Other

10-mL washout with saline based ocular rinse post injection for Intravitreal Injections

N/A
Waitlist Available
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
choroidal neovascular membrane or cystoid macular edema requiring intravitreal injections for treatment.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24-72 hours after injection
Awards & highlights

Summary

This is the first randomized controlled trial looking into post-injection rinse volume of standard ophthalmic eyewash and its affect on patient comfort up to 72 hours after injections.

Eligible Conditions
  • Intravitreal Injections
  • Macular Edema
  • Age-Related Macular Degeneration
  • Eye Irrigation
  • Diabetic Macular Edema

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24-72 hours after injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24-72 hours after injection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ocular Surface Disease Index
Secondary outcome measures
Eye

Trial Design

3Treatment groups
Experimental Treatment
Group I: 3-mL washout with saline based ocular rinse post injectionExperimental Treatment2 Interventions
Group II: 15-mL washout with saline based ocular rinse post injectionExperimental Treatment2 Interventions
Group III: 10-mL washout with saline based ocular rinse post injectionExperimental Treatment2 Interventions

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
464 Previous Clinical Trials
90,991 Total Patients Enrolled
~32 spots leftby Sep 2025